Authors: VANDENBARK AA CHOU YK WHITMAN R MASS R BUENAFE A LIEFELD D KAVANAGH D COOPER S HASHIM GA OFFNER H BOURDETTE DN

Citation: Aa. Vandenbark et al., TREATMENT OF MULTIPLE-SCLEROSIS WITH T-CELL RECEPTOR PEPTIDES - RESULTS OF A DOUBLE-BLIND PILOT TRIAL (VOL 2, PG 1109, 1996), Nature medicine, 3(2), 1997, pp. 240-240

Authors: VANDENBARK AA CHOU YK WHITHAM R MASS M BUENAFE A LIEFELD D KAVANAGH D COOPER S HASHIM GA OFFNER H BOURDETTE DN

Citation: Aa. Vandenbark et al., TREATMENT OF MULTIPLE-SCLEROSIS WITH T-CELL RECEPTOR PEPTIDES - RESULTS OF A DOUBLE-BLIND PILOT TRIAL, Nature medicine, 2(10), 1996, pp. 1109-1115

Authors: VANDENBARK AA CHOU YK WHITHAM R BUENAFE A LIEFELD D CAVANAGH D COOPER S HASHIM GA OFFNER H BOURDETTE D

Citation: Aa. Vandenbark et al., TCR PEPTIDE VACCINATION INDUCED TH2 IMMUNE REGULATION IN MULTIPLE-SCLEROSIS, The FASEB journal, 10(6), 1996, pp. 933-933

Authors: BOURDETTE DN WHITHAM RH CHOU YK MORRISON WJ ATHERTON J KENNY C LIEFELD D HASHIM GA OFFNER H VANDENBARK AA

Citation: Dn. Bourdette et al., IMMUNITY TO TCR PEPTIDES IN MULTIPLE-SCLEROSIS .1. SUCCESSFUL IMMUNIZATION OF PATIENTS WITH SYNTHETIC V-BETA-5.2 AND V-BETA-6.1 CDR2 PEPTIDES, The Journal of immunology, 152(5), 1994, pp. 2510-2519